Jean-Frederic Viret - 05 Feb 2026 Form 3 Insider Report for SpyGlass Pharma, Inc. (SGP)

Signature
/s/ Brian Aukshunas, as Attorney-in-Fact
Issuer symbol
SGP
Transactions as of
05 Feb 2026
Net transactions value
$0
Form type
3
Filing time
05 Feb 2026, 13:02:52 UTC
Previous filing
08 Apr 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Viret Jean-Frederic Chief Financial Officer C/O SPYGLASS PHARMA, INC., 27061 ALISO CREEK RD., SUITE 100, ALISO VIEJO /s/ Brian Aukshunas, as Attorney-in-Fact 05 Feb 2026 0001427569

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGP Stock Option (right to buy) 05 Feb 2026 Common Stock 263,907 $10.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean January 1, 2026.

Remarks:

Exhibit 24 - Power of Attorney